Reproductive Surgery · Definitive and Ablative Procedures
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs)
Pierconti F, Martini M, Grande G, Larocca LM, Sacco E, Pugliese D, Gulino G, Bassi PF, Milardi D, Pontecorvi A
Cite this paper
Pierconti, F., Martini, M., Grande, G., Larocca, L. M., Sacco, E., Pugliese, D., Gulino, G., Bassi, P. F., Milardi, D., & Pontecorvi, A. (2019). Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs). Frontiers in endocrinology. https://doi.org/10.3389/fendo.2019.00512
Pierconti F, Martini M, Grande G, Larocca LM, Sacco E, Pugliese D, Gulino G, Bassi PF, Milardi D, Pontecorvi A. Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs). Frontiers in endocrinology. 2019. doi:10.3389/fendo.2019.00512
Pierconti, Francesco, et al. "Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs)." Frontiers in endocrinology, 2019.
For EndNote, Zotero or Mendeley:
Open access
No open license is recorded for this paper. Reuse terms are set by the publisher.
Open Access
Free full text on PubMed Central (PMC6692875)